SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 41 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $146 | -98.0% | 139 | -97.9% | 0.00% | – |
| Q2 2023 | $7,423 | +43.9% | 6,511 | +89.3% | 0.00% | – |
| Q1 2023 | $5,160 | +215.6% | 3,440 | +213.6% | 0.00% | – |
| Q4 2022 | $1,635 | -91.8% | 1,097 | -91.6% | 0.00% | – |
| Q3 2022 | $20,000 | -35.5% | 13,114 | -2.6% | 0.00% | – |
| Q2 2022 | $31,000 | 0.0% | 13,463 | -1.1% | 0.00% | – |
| Q1 2022 | $31,000 | -76.2% | 13,618 | -39.2% | 0.00% | – |
| Q4 2021 | $130,000 | +1081.8% | 22,402 | +2120.2% | 0.00% | – |
| Q3 2021 | $11,000 | +57.1% | 1,009 | +45.4% | 0.00% | – |
| Q2 2021 | $7,000 | -77.4% | 694 | -66.9% | 0.00% | – |
| Q1 2021 | $31,000 | – | 2,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 650,000 | $403,065 | 0.07% |
| Deuterium Capital Management, LLC | 11,000 | $6,821 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 172,835 | $107,175 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 77,900 | $48,306 | 0.00% |
| XTX Topco Ltd | 14,047 | $8,711 | 0.00% |
| Leo Wealth, LLC | 14,845 | $9,205 | 0.00% |
| NORTHERN TRUST CORP | 25,983 | $16,112 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Cresset Asset Management, LLC | 19,671 | $12,198 | 0.00% |
| Banque Cantonale Vaudoise | 3,900 | $2 | 0.00% |